These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Etiologies of chronic renal insufficiency in a adult internal medicine service in Dakar]. Diouf B, Ka EF, Niang A, Diouf ML, Mbengue M, Diop TM. Dakar Med; 2000; 45(1):62-5. PubMed ID: 14666794 [Abstract] [Full Text] [Related]
23. Relationship between hydrocarbon exposure and nephropathology in primary glomerulonephritis. Yaqoob M, King A, McClelland P, McDicken I, Bell GM. Nephrol Dial Transplant; 1994; 9(11):1575-9. PubMed ID: 7870345 [Abstract] [Full Text] [Related]
24. [Relation of serum erythropoietin concentration to erythropoiesis in different chronic kidney diseases and stages of kidney failure]. Jahn CH. Wien Klin Wochenschr; 1993; 105(11):327-9. PubMed ID: 8333200 [No Abstract] [Full Text] [Related]
25. [Particularly severe calcium metabolic disorder in nephropathy from analgesic abuse]. Jaeger P, Burckhardt P, Wauters JP, Trechsel U, Bonjour JP. Schweiz Med Wochenschr; 1982 Dec 04; 112(49):1791-4. PubMed ID: 7178876 [Abstract] [Full Text] [Related]
26. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria. Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F. Nephrol Dial Transplant; 1993 Dec 04; 8(12):1333-7. PubMed ID: 8159301 [Abstract] [Full Text] [Related]
27. [Influence of blood pressure on the progression rate of advanced chronic renal insufficiency]. Hannedouche T, Chauveau P, Ferhat A, Loubaris T, Jungers P. Arch Mal Coeur Vaiss; 1988 Jun 04; 81 Spec No():203-6. PubMed ID: 3142408 [Abstract] [Full Text] [Related]
33. Age-related differences in renal function at onset of renal replacement therapy in chronic kidney disease stage 5 patients. Balogun SA, Balogun RA, Evans J. QJM; 2006 Sep 04; 99(9):595-9. PubMed ID: 16905750 [Abstract] [Full Text] [Related]
34. Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure. Tomson CR, Channon SM, Parkinson IS, Morley AR, Lennard TW, Parrott NR, Laker MF. J Clin Pathol; 1988 Oct 04; 41(10):1107-13. PubMed ID: 3192733 [Abstract] [Full Text] [Related]
35. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis. Ahmad S, Hatch M. Nephron; 1985 Oct 04; 41(3):235-40. PubMed ID: 4058624 [Abstract] [Full Text] [Related]
36. Erythropoietin and anemia in the progression of Balkan endemic nephropathy and other renal diseases. Pavlović-Kentera V, Clemons GK, Trbojević S, Dimković N, Djukanović L. Nephron; 1990 Oct 04; 54(2):139-43. PubMed ID: 2314525 [Abstract] [Full Text] [Related]
37. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both. Constable AR, Joekes AM, Kasidas GP, O'Regan P, Rose GA. Clin Sci (Lond); 1979 Apr 04; 56(4):299-304. PubMed ID: 477214 [Abstract] [Full Text] [Related]
39. The determination of plasma oxalate concentrations using an enzyme/bioluminescent assay. 2. Co-immobilisation of bioluminescent enzymes and studies of in vitro oxalogenesis. Parkinson IS, Channon SM, Tomson CR, Adonai LR, Ward MK, Laker MF. Clin Chim Acta; 1989 Jan 13; 179(1):97-108. PubMed ID: 2920444 [Abstract] [Full Text] [Related]